{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"thymosin-alpha-1","name":"Thymosin alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":48,"objects":{"clinicaltrials-gov-nct00001036-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00001036-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct00001036-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00001036-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct00001036-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct00001036-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct00001036-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2008-07-30","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00001036","sourceIds":["ctg-observation-nct00001036-2008-07-30-c6f83c4e50e1"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00001036 at 2026-11-15T22:10:40.222Z. Its registry update date was 2008-07-30, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct00001036-2008-07-30-c6f83c4e50e1"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00001036 at 2026-11-15T22:10:40.222Z. Its registry update date was 2008-07-30, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct00001036-2008-07-30-c6f83c4e50e1"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00001036-2008-07-30-c6f83c4e50e1"]}],"sources":[{"id":"ctg-observation-nct00001036-2008-07-30-c6f83c4e50e1","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00001036 · retained source version 2008-07-30:c6f83c4e50e195abf2a18bae43cf8818e49f859c1b65c232eb44c3267115c994","url":"https://clinicaltrials.gov/study/NCT00001036"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d64168c2a8e6e271a3c6f15adfda81ffc65c6316960006cb7eb0c7ed95a1086f","tierARecordSha256":"b716e867f73ac1acb9bdd724540073b53c5a09b2d1a6e3d026abec359d9cdec4"},"integrity":{"algorithm":"sha256","contentSha256":"b1584e6b0b4638394a3392031c55b75c09d872408b16123157a5308376479a63"}},"clinicaltrials-gov-nct00711620-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00711620-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct00711620-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00711620-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct00711620-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct00711620-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct00711620-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2011-06-14","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00711620","sourceIds":["ctg-observation-nct00711620-2011-06-14-51885124a914"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00711620 at 2026-11-15T22:10:40.222Z. Its registry update date was 2011-06-14, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct00711620-2011-06-14-51885124a914"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00711620 at 2026-11-15T22:10:40.222Z. Its registry update date was 2011-06-14, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct00711620-2011-06-14-51885124a914"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00711620-2011-06-14-51885124a914"]}],"sources":[{"id":"ctg-observation-nct00711620-2011-06-14-51885124a914","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00711620 · retained source version 2011-06-14:51885124a914c8d2fc36c6017bbf5bda8f574f50ec595082552af29a995e5104","url":"https://clinicaltrials.gov/study/NCT00711620"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4c9fee5aba2a290e1711b4fa8b155eb292798c93d02221b75c3c114675e7524b","tierARecordSha256":"71f6003519c8c094eff84a9b18dbea52d7802b7c9ce2087b0a903af704a29f35"},"integrity":{"algorithm":"sha256","contentSha256":"d74464e1fd8a8b6cdce3d88ef496906606f0154cdac99779b5e37946148621f9"}},"clinicaltrials-gov-nct00911443-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00911443-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct00911443-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00911443-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct00911443-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct00911443-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct00911443-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2009-07-09","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00911443","sourceIds":["ctg-observation-nct00911443-2009-07-09-e5373ac11104"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00911443 at 2026-11-15T22:10:40.222Z. Its registry update date was 2009-07-09, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct00911443-2009-07-09-e5373ac11104"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00911443 at 2026-11-15T22:10:40.222Z. Its registry update date was 2009-07-09, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct00911443-2009-07-09-e5373ac11104"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00911443-2009-07-09-e5373ac11104"]}],"sources":[{"id":"ctg-observation-nct00911443-2009-07-09-e5373ac11104","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00911443 · retained source version 2009-07-09:e5373ac1110483b7efc0022ad5c16f6221a6c82367f9fa7857794e7816050842","url":"https://clinicaltrials.gov/study/NCT00911443"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ad73757f210dd242b58d2d1a190174b664454bf2f2d96bf753bd8f551086c856","tierARecordSha256":"3fd3a1136911147ed1de5e044bc4f612f67622df98fda74f5ad3093735d44578"},"integrity":{"algorithm":"sha256","contentSha256":"66e9e146693895d56a006d85aec6f3fb3ddb6727fb2f18249ea286a11780203d"}},"clinicaltrials-gov-nct01031966-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01031966-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct01031966-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01031966-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct01031966-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct01031966-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct01031966-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2012-03-29","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01031966","sourceIds":["ctg-observation-nct01031966-2012-03-29-16ac79aaa2af"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01031966 at 2026-11-15T22:10:40.222Z. Its registry update date was 2012-03-29, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct01031966-2012-03-29-16ac79aaa2af"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01031966 at 2026-11-15T22:10:40.222Z. Its registry update date was 2012-03-29, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct01031966-2012-03-29-16ac79aaa2af"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01031966-2012-03-29-16ac79aaa2af"]}],"sources":[{"id":"ctg-observation-nct01031966-2012-03-29-16ac79aaa2af","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01031966 · retained source version 2012-03-29:16ac79aaa2afafdfd404ed1bfd8d4219d2e24fc6b26d6678ee0b2170428bbaff","url":"https://clinicaltrials.gov/study/NCT01031966"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a1ccff007957f556e5d0014ab34658f467b31b99c449fcc6caf99fc828329f54","tierARecordSha256":"076c90613b3189f9d7fc138c72513beee7832e702b8932999c4ece15bf73caba"},"integrity":{"algorithm":"sha256","contentSha256":"089f6f7d8b0d98f78111f97a482c14aa746621ccd06e3e33b317c5bf753df049"}},"clinicaltrials-gov-nct01178996-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01178996-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct01178996-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01178996-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct01178996-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct01178996-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct01178996-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2010-08-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01178996","sourceIds":["ctg-observation-nct01178996-2010-08-10-684dcd5dc87f"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01178996 at 2026-11-15T22:10:40.222Z. Its registry update date was 2010-08-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct01178996-2010-08-10-684dcd5dc87f"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01178996 at 2026-11-15T22:10:40.222Z. Its registry update date was 2010-08-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct01178996-2010-08-10-684dcd5dc87f"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01178996-2010-08-10-684dcd5dc87f"]}],"sources":[{"id":"ctg-observation-nct01178996-2010-08-10-684dcd5dc87f","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01178996 · retained source version 2010-08-10:684dcd5dc87f473bb9ebcf91674b0fe616f9a2006aac8945e1dc2e9173345960","url":"https://clinicaltrials.gov/study/NCT01178996"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a2cd1e1a7125aeed3967fb15691d8ce43c2d9fc25aa23bce99d6a9b8cd71b21f","tierARecordSha256":"35c61af7569a5ee9c2e2d80c24b6a9b367dae1324fd8c236dc89a152701fd393"},"integrity":{"algorithm":"sha256","contentSha256":"2c002511edfb714083a805dd18e6615af27e02d1fe0d77f8e1e7e6d96d8233f9"}},"clinicaltrials-gov-nct02473406-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02473406-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct02473406-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02473406-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02473406-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct02473406-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct02473406-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2021-04-05","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02473406","sourceIds":["ctg-observation-nct02473406-2021-04-05-0155375039ca"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02473406 at 2026-11-15T22:10:40.222Z. Its registry update date was 2021-04-05, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct02473406-2021-04-05-0155375039ca"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02473406 at 2026-11-15T22:10:40.222Z. Its registry update date was 2021-04-05, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct02473406-2021-04-05-0155375039ca"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02473406-2021-04-05-0155375039ca"]}],"sources":[{"id":"ctg-observation-nct02473406-2021-04-05-0155375039ca","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02473406 · retained source version 2021-04-05:0155375039ca802db3b3739ea7b8cbdff1afcbe1c5dcc4e874aaa7b2da6907a8","url":"https://clinicaltrials.gov/study/NCT02473406"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"715a27bb28aff4d2f5aee48e9bb161068769d07d035cf1eff2494a90007d4650","tierARecordSha256":"c5e6698acaf0f0165d873a93935a805f20e54b653aad58fb5e4694ad47d932ff"},"integrity":{"algorithm":"sha256","contentSha256":"9182c1012c5448e844f9594c5f510cfbf3c62f8c11b28dec4547350b30836ace"}},"clinicaltrials-gov-nct02646189-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02646189-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct02646189-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02646189-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02646189-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct02646189-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct02646189-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2016-01-05","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02646189","sourceIds":["ctg-observation-nct02646189-2016-01-05-5d1291c4c493"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02646189 at 2026-11-15T22:10:40.222Z. Its registry update date was 2016-01-05, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct02646189-2016-01-05-5d1291c4c493"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02646189 at 2026-11-15T22:10:40.222Z. Its registry update date was 2016-01-05, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct02646189-2016-01-05-5d1291c4c493"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02646189-2016-01-05-5d1291c4c493"]}],"sources":[{"id":"ctg-observation-nct02646189-2016-01-05-5d1291c4c493","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02646189 · retained source version 2016-01-05:5d1291c4c49337624b93a4badce6b80d57a2560e293cb566d4ca5a946ac7a5c2","url":"https://clinicaltrials.gov/study/NCT02646189"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"96c03966066924022165a348e530a765cd55d998559d5cd96ebbf866a6f6ad1a","tierARecordSha256":"de0aabc79056664d0691bd57904ae5e8cc8d7a21b7c47bbfbb10664e7df0e101"},"integrity":{"algorithm":"sha256","contentSha256":"f31dc53f9301a4f40dd43dd676418dfa13bfaf37eb5ac5783cca347614be1e2a"}},"clinicaltrials-gov-nct02867267-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02867267-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct02867267-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02867267-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02867267-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct02867267-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct02867267-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2023-04-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02867267","sourceIds":["ctg-observation-nct02867267-2023-04-10-b86f32ef72aa"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02867267 at 2026-11-15T22:10:40.222Z. Its registry update date was 2023-04-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct02867267-2023-04-10-b86f32ef72aa"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02867267 at 2026-11-15T22:10:40.222Z. Its registry update date was 2023-04-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct02867267-2023-04-10-b86f32ef72aa"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02867267-2023-04-10-b86f32ef72aa"]}],"sources":[{"id":"ctg-observation-nct02867267-2023-04-10-b86f32ef72aa","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02867267 · retained source version 2023-04-10:b86f32ef72aa30e7e8e1cd93079f8a0ac2826e9d6830896e9929bf56c7c10158","url":"https://clinicaltrials.gov/study/NCT02867267"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b6521033d9de94d04adcdd323f62e29c907d5f6761e738840fd524878b4e5575","tierARecordSha256":"61c232975492fb633e14ac90012bf2cab1764ab5c50bc1d3ce1e237d59bf195a"},"integrity":{"algorithm":"sha256","contentSha256":"d0e602446e2ec1d874423af4864423d8a77dbe65dba327c90c95679261def169"}},"clinicaltrials-gov-nct02883595-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02883595-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct02883595-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02883595-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct02883595-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct02883595-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct02883595-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2019-04-04","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02883595","sourceIds":["ctg-observation-nct02883595-2019-04-04-c729fc9aadc8"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02883595 at 2026-11-15T22:10:40.222Z. Its registry update date was 2019-04-04, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct02883595-2019-04-04-c729fc9aadc8"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02883595 at 2026-11-15T22:10:40.222Z. Its registry update date was 2019-04-04, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct02883595-2019-04-04-c729fc9aadc8"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02883595-2019-04-04-c729fc9aadc8"]}],"sources":[{"id":"ctg-observation-nct02883595-2019-04-04-c729fc9aadc8","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02883595 · retained source version 2019-04-04:c729fc9aadc8a18ca1f3725165c51cffee129f1fce75c74d61e40e449645f611","url":"https://clinicaltrials.gov/study/NCT02883595"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7d6890c087bf2f962bbf359e7743e04f46fc9403b16f10079390d9dac9106613","tierARecordSha256":"cf60743c2d0c1b9e24b8aa00e924a2d2185f029275406d9b08e4fc7b15413282"},"integrity":{"algorithm":"sha256","contentSha256":"508ef05d09f353734dd51d550e32faed7775a468093bfb690c492eb0b73d8e96"}},"clinicaltrials-gov-nct03659578-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03659578-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct03659578-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03659578-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct03659578-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct03659578-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct03659578-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2022-01-03","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03659578","sourceIds":["ctg-observation-nct03659578-2022-01-03-4144f9702a2e"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03659578 at 2026-11-15T22:10:40.222Z. Its registry update date was 2022-01-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct03659578-2022-01-03-4144f9702a2e"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03659578 at 2026-11-15T22:10:40.222Z. Its registry update date was 2022-01-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct03659578-2022-01-03-4144f9702a2e"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03659578-2022-01-03-4144f9702a2e"]}],"sources":[{"id":"ctg-observation-nct03659578-2022-01-03-4144f9702a2e","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03659578 · retained source version 2022-01-03:4144f9702a2ed3cfe271e66f674bade8ddd0b2606deb4cf8f8380233b9e4ebca","url":"https://clinicaltrials.gov/study/NCT03659578"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d8929491ca2231caab3cf83adec9451efbc40286600c96034b83d3f8d1c657bc","tierARecordSha256":"cbc30fd5d908573544091b9d19c524c098642ece9a3db801ed17ba211a8e5896"},"integrity":{"algorithm":"sha256","contentSha256":"dc5b8896f8af88d38d1151d1ac62930554cb29510260537679e3427b6b78b991"}},"clinicaltrials-gov-nct04428008-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04428008-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct04428008-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04428008-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct04428008-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct04428008-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct04428008-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2026-04-21","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04428008","sourceIds":["ctg-observation-nct04428008-2026-04-21-793d18956433"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04428008 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct04428008-2026-04-21-793d18956433"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04428008 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct04428008-2026-04-21-793d18956433"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04428008-2026-04-21-793d18956433"]}],"sources":[{"id":"ctg-observation-nct04428008-2026-04-21-793d18956433","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04428008 · retained source version 2026-04-21:793d18956433a6b95a3ff2ad903e14b4523f84974b223bf8b327d05389e16d65","url":"https://clinicaltrials.gov/study/NCT04428008"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"20ba919be9757c82b288757ea180ac4122f2e679f6290b867cb0a4e94366f150","tierARecordSha256":"f3514a696b324b73a50805c38306f8eeace6debd3c46ef993cf3ee1def474acd"},"integrity":{"algorithm":"sha256","contentSha256":"95208c27599d5931e45edd8e5cb831adc77686ea4a15f5d8a81137a565a4dac5"}},"clinicaltrials-gov-nct05086614-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05086614-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct05086614-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05086614-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct05086614-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct05086614-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct05086614-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2021-10-21","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05086614","sourceIds":["ctg-observation-nct05086614-2021-10-21-1fa7f4870c8e"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05086614 at 2026-11-15T22:10:40.222Z. Its registry update date was 2021-10-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct05086614-2021-10-21-1fa7f4870c8e"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05086614 at 2026-11-15T22:10:40.222Z. Its registry update date was 2021-10-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct05086614-2021-10-21-1fa7f4870c8e"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05086614-2021-10-21-1fa7f4870c8e"]}],"sources":[{"id":"ctg-observation-nct05086614-2021-10-21-1fa7f4870c8e","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05086614 · retained source version 2021-10-21:1fa7f4870c8e18dd0588d15d158216de403e012192fde3e5a6673962c69a6044","url":"https://clinicaltrials.gov/study/NCT05086614"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f5b24182a81626182de6381203f62001c2ca21a60cea925be98ee5bbd6d4b056","tierARecordSha256":"e4606a1256806186e3489e813cc4518149d07c394855290744648a4fca77d684"},"integrity":{"algorithm":"sha256","contentSha256":"d3e955c5dc3415bf9fca2e228253871ba5e685fffdd718cb60c0e8e5ef68a730"}},"clinicaltrials-gov-nct06024356-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06024356-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct06024356-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06024356-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct06024356-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct06024356-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct06024356-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2026-06-18","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06024356","sourceIds":["ctg-observation-nct06024356-2026-06-18-6263381379e8"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06024356 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct06024356-2026-06-18-6263381379e8"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06024356 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct06024356-2026-06-18-6263381379e8"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06024356-2026-06-18-6263381379e8"]}],"sources":[{"id":"ctg-observation-nct06024356-2026-06-18-6263381379e8","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06024356 · retained source version 2026-06-18:6263381379e88846f274192a97475f4d194b78009cc6154ed086fbcd55030de2","url":"https://clinicaltrials.gov/study/NCT06024356"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"23d946d1a27c883c3d807ec1e95276dd08fae9976d34e74e28b92ad3905b82de","tierARecordSha256":"0a87a9b5a02c43322cd9c366ea0525d2cd17d658feb2c1eb17823893d1e52070"},"integrity":{"algorithm":"sha256","contentSha256":"d9dae2610f260145af363e77f60aa938e7017bd2f3de012b0a27823aad19b362"}},"clinicaltrials-gov-nct06139419-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06139419-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct06139419-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06139419-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct06139419-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct06139419-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct06139419-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2026-08-03","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06139419","sourceIds":["ctg-observation-nct06139419-2026-08-03-0a01c8ce97bf"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06139419 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct06139419-2026-08-03-0a01c8ce97bf"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06139419 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct06139419-2026-08-03-0a01c8ce97bf"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06139419-2026-08-03-0a01c8ce97bf"]}],"sources":[{"id":"ctg-observation-nct06139419-2026-08-03-0a01c8ce97bf","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06139419 · retained source version 2026-08-03:0a01c8ce97bfd8dc6124a03c4b9e44d0a41ab9052875084ff79ff1f7e03338af","url":"https://clinicaltrials.gov/study/NCT06139419"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a8ebaedc074184f734b24b8359500bc120c58ab06eb9e77b3234110c99c8b323","tierARecordSha256":"98849ccc7b18b880ee7559d9d7c4b193235f9c6b0a8d899abb6c2fc18e5165e7"},"integrity":{"algorithm":"sha256","contentSha256":"1ac334f5a0ecfb48be3ac24b79711ec0038573f844b60789cf9e56ac3a41ea6d"}},"clinicaltrials-gov-nct06461910-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06461910-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct06461910-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06461910-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct06461910-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct06461910-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct06461910-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2026-03-03","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06461910","sourceIds":["ctg-observation-nct06461910-2026-03-03-059bac03445d"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06461910 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-03-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct06461910-2026-03-03-059bac03445d"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06461910 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-03-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct06461910-2026-03-03-059bac03445d"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06461910-2026-03-03-059bac03445d"]}],"sources":[{"id":"ctg-observation-nct06461910-2026-03-03-059bac03445d","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06461910 · retained source version 2026-03-03:059bac03445db3615d2c3ef7db745e78c8f4faac786186b3540ea3c693b5f87a","url":"https://clinicaltrials.gov/study/NCT06461910"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d5ddfce70f7684c2855bfe4bb4027e32f7be5f95a47bf5d599dc82fd3afac702","tierARecordSha256":"1af1a5c7cfa056a9d44048b89f0741a4f299c6e692e51c05b0db3582e07a1d9a"},"integrity":{"algorithm":"sha256","contentSha256":"91a60b21b1fb748d492acfde05a9886632d9004cbe4ca813f962f6973f517e65"}},"clinicaltrials-gov-nct07780721-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07780721-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct07780721-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07780721-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct07780721-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct07780721-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct07780721-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2026-08-21","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07780721","sourceIds":["ctg-observation-nct07780721-2026-08-21-eac5dfa235e1"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07780721 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct07780721-2026-08-21-eac5dfa235e1"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07780721 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct07780721-2026-08-21-eac5dfa235e1"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07780721-2026-08-21-eac5dfa235e1"]}],"sources":[{"id":"ctg-observation-nct07780721-2026-08-21-eac5dfa235e1","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07780721 · retained source version 2026-08-21:eac5dfa235e145cc284335cbc73f74170f0690955227106a5bd112f480dd7d24","url":"https://clinicaltrials.gov/study/NCT07780721"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"071698383993f2e7fb3c510edc65a40dccb9f4fd405cf1330a3e88b7f639273b","tierARecordSha256":"91e6c977b13bbde26998e422a9d681385ea08c820cf00baca945a2b97347c519"},"integrity":{"algorithm":"sha256","contentSha256":"e34ca6a34433f828fe4f26fbdb9f83b642aa0a1ecc9d193a2743bc735825cbb4"}},"clinicaltrials-gov-nct07884201-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07884201-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct07884201-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07884201-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct07884201-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct07884201-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct07884201-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2026-10-20","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07884201","sourceIds":["ctg-observation-nct07884201-2026-10-20-ed94c2343a31"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07884201 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-10-20, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct07884201-2026-10-20-ed94c2343a31"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07884201 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-10-20, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct07884201-2026-10-20-ed94c2343a31"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07884201-2026-10-20-ed94c2343a31"]}],"sources":[{"id":"ctg-observation-nct07884201-2026-10-20-ed94c2343a31","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07884201 · retained source version 2026-10-20:ed94c2343a31cffc8f27134bb82a7294ed0dd408721b8556aee388a2da690c87","url":"https://clinicaltrials.gov/study/NCT07884201"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1438201e9f84860e7b64c77b579b47af26edd075b5902ce1dfe5336249852025","tierARecordSha256":"483195480bb0a58dda737caec076059a765331bd949154a0fad500ebdbb2364e"},"integrity":{"algorithm":"sha256","contentSha256":"747e1f6c298cd610c13f332d5581e66154719729353330a7f4ba7babd69d5f84"}},"clinicaltrials-gov-nct07922954-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07922954-thymosin-alpha-1:v1","objectPathId":"clinicaltrials-gov-nct07922954-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07922954-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#clinicaltrials-gov-nct07922954-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#clinicaltrials-gov-nct07922954-thymosin-alpha-1-v1"},"story":{"slug":"clinicaltrials-gov-nct07922954-thymosin-alpha-1","version":1,"domain":"Clinical trials","dateInSource":"2026-11-06","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07922954","sourceIds":["ctg-observation-nct07922954-2026-11-06-ed3cdbf8f3d0"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07922954 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-11-06, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct07922954-2026-11-06-ed3cdbf8f3d0"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07922954 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-11-06, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.","sourceIds":["ctg-observation-nct07922954-2026-11-06-ed3cdbf8f3d0"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07922954-2026-11-06-ed3cdbf8f3d0"]}],"sources":[{"id":"ctg-observation-nct07922954-2026-11-06-ed3cdbf8f3d0","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07922954 · retained source version 2026-11-06:ed3cdbf8f3d019a0155cbd96898584ab2d6e82ada6a3a9abeb8f82e77b6f5a0d","url":"https://clinicaltrials.gov/study/NCT07922954"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4df2ecd84fed54e1c329f671086320b4031c1a479b3b662c4ac0bf7205012d87","tierARecordSha256":"5f0827ad9bfb8eda3af2af293bf2f9015b2492ce1c7542c0fe0766f94ba5e104"},"integrity":{"algorithm":"sha256","contentSha256":"18c6a257d4ec7a2410e3cef1f2e10788dfa56779cadfa1ed332d11696797ae34"}},"pubmed-pmid-11381492-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-11381492-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-11381492-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-11381492-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-11381492-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-11381492-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-11381492-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2019-02-22","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymosin alpha-1.","sourceIds":["pubmed-observation-pmid-11381492-2019-02-22-73b82868b925"]},{"id":"summary","text":"PubMed lists PMID 11381492 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, Review, with publication-date metadata of 2001-05-15 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-11381492-2019-02-22-73b82868b925"]},{"id":"paragraph-1","text":"PubMed lists PMID 11381492 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, Review, with publication-date metadata of 2001-05-15 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-11381492-2019-02-22-73b82868b925"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-11381492-2019-02-22-73b82868b925"]}],"sources":[{"id":"pubmed-observation-pmid-11381492-2019-02-22-73b82868b925","name":"PubMed","sourceClass":"A","title":"Thymosin alpha-1. · retained source version 1:2019-02-22:current:73b82868b9259b13a4df4593554042a6a29d09306e94b76b54fa72f5f2452f21","url":"https://pubmed.ncbi.nlm.nih.gov/11381492/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a90562ff374ee7a35cdf9cede67896634c8bcee6fc638c6302a35363b79c25bb","tierARecordSha256":"9518e6905ab167238a1081409b9658d43c5b68abb43ece5cec32f3808df1a0a0"},"integrity":{"algorithm":"sha256","contentSha256":"533afdb9fe9d863176233dab8a2a726953a8228283f8df87b4882aabc7655a94"}},"pubmed-pmid-12860169-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-12860169-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-12860169-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-12860169-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-12860169-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-12860169-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-12860169-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-11-30","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer.","sourceIds":["pubmed-observation-pmid-12860169-2018-11-30-0844747aad75"]},{"id":"summary","text":"PubMed lists PMID 12860169 in International immunopharmacology as Journal Article, Review, with publication-date metadata of 2003-08 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-12860169-2018-11-30-0844747aad75"]},{"id":"paragraph-1","text":"PubMed lists PMID 12860169 in International immunopharmacology as Journal Article, Review, with publication-date metadata of 2003-08 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-12860169-2018-11-30-0844747aad75"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-12860169-2018-11-30-0844747aad75"]}],"sources":[{"id":"pubmed-observation-pmid-12860169-2018-11-30-0844747aad75","name":"PubMed","sourceClass":"A","title":"Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer. · retained source version 1:2018-11-30:current:0844747aad755d345f761e83816fa916d83c3f3a0eed38dd581442662c36ef90","url":"https://pubmed.ncbi.nlm.nih.gov/12860169/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c71c06a4d8070ade8ede45eaff91d2be72c3661a9c6fc3329f2db03d6f420d17","tierARecordSha256":"316be15be5c17282b3f48fb60b7cc22851201e6ef28bb1d7ccb38e7d53bb4ef0"},"integrity":{"algorithm":"sha256","contentSha256":"9ac6e6a1d22f88eef289200952279e8294fc16cf823e80de0b5086903e1c3ec5"}},"pubmed-pmid-15482167-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-15482167-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-15482167-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-15482167-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15482167-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-15482167-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-15482167-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2019-11-09","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymalfasin for the treatment of chronic hepatitis B.","sourceIds":["pubmed-observation-pmid-15482167-2019-11-09-721edf86da03"]},{"id":"summary","text":"PubMed lists PMID 15482167 in Expert review of anti-infective therapy as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2004-02 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15482167-2019-11-09-721edf86da03"]},{"id":"paragraph-1","text":"PubMed lists PMID 15482167 in Expert review of anti-infective therapy as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2004-02 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15482167-2019-11-09-721edf86da03"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-15482167-2019-11-09-721edf86da03"]}],"sources":[{"id":"pubmed-observation-pmid-15482167-2019-11-09-721edf86da03","name":"PubMed","sourceClass":"A","title":"Thymalfasin for the treatment of chronic hepatitis B. · retained source version 1:2019-11-09:current:721edf86da035d59960222b1ac5bb422d5fa3fbfe395f219fa602500019d0061","url":"https://pubmed.ncbi.nlm.nih.gov/15482167/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c311f2e90c9d2986df58ed282657f3fd648e588de1a0485891d9585d79b6c79c","tierARecordSha256":"7d976f06d240814037ac2a5df038bc61abc9ee878d84180e5edc140e6121e9bd"},"integrity":{"algorithm":"sha256","contentSha256":"4353927f2ca3a199c982b5478abca89692adb56e0045f02620b66b567174f7f5"}},"pubmed-pmid-15546255-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-15546255-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-15546255-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-15546255-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15546255-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-15546255-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-15546255-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2026-01-28","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.","sourceIds":["pubmed-observation-pmid-15546255-2026-01-28-ee7e29fa834d"]},{"id":"summary","text":"PubMed lists PMID 15546255 in Journal of gastroenterology and hepatology as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15546255-2026-01-28-ee7e29fa834d"]},{"id":"paragraph-1","text":"PubMed lists PMID 15546255 in Journal of gastroenterology and hepatology as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15546255-2026-01-28-ee7e29fa834d"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-15546255-2026-01-28-ee7e29fa834d"]}],"sources":[{"id":"pubmed-observation-pmid-15546255-2026-01-28-ee7e29fa834d","name":"PubMed","sourceClass":"A","title":"Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment. · retained source version 1:2026-01-28:current:ee7e29fa834d3cdfa9f4ee3dd5e2854f538d3823cfb5cf018066be4145009276","url":"https://pubmed.ncbi.nlm.nih.gov/15546255/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6a490eb328520aa372adb7f04778ff9e211bb61e1ba10f58bfe047d48e4ea3b0","tierARecordSha256":"573ff6818e2d2a4e5c00016ed825d6c3299b3b3a417beb6957028b7eb06d2980"},"integrity":{"algorithm":"sha256","contentSha256":"074b46d9d0086029d53b63a629466b392413050c6b4b38c37ede2b958b249cbd"}},"pubmed-pmid-15641208-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-15641208-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-15641208-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-15641208-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15641208-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-15641208-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-15641208-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.","sourceIds":["pubmed-observation-pmid-15641208-2018-12-01-0f714efb558b"]},{"id":"summary","text":"PubMed lists PMID 15641208 in Journal of gastroenterology and hepatology as Journal Article, Review, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15641208-2018-12-01-0f714efb558b"]},{"id":"paragraph-1","text":"PubMed lists PMID 15641208 in Journal of gastroenterology and hepatology as Journal Article, Review, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15641208-2018-12-01-0f714efb558b"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-15641208-2018-12-01-0f714efb558b"]}],"sources":[{"id":"pubmed-observation-pmid-15641208-2018-12-01-0f714efb558b","name":"PubMed","sourceClass":"A","title":"Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B. · retained source version 1:2018-12-01:current:0f714efb558b2c38a29205517b8a9a0fc5bae1ac7fb6817d38101bd2f5d1e307","url":"https://pubmed.ncbi.nlm.nih.gov/15641208/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1c3203f372c71f24c2b9d5a19b500440349caae3c4f2a1fa72facc4581ca916a","tierARecordSha256":"28b9830c898ee9c001bfc944fd8beec22a14ebd239e07e1e57259ce2a14cc5de"},"integrity":{"algorithm":"sha256","contentSha256":"5214f4aacba0d149428f4c570f0c6d8b58d586bff4e8bbb63ecbe1c1293194f4"}},"pubmed-pmid-15641209-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-15641209-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-15641209-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-15641209-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-15641209-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-15641209-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-15641209-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.","sourceIds":["pubmed-observation-pmid-15641209-2018-12-01-b9b14dc42eb4"]},{"id":"summary","text":"PubMed lists PMID 15641209 in Journal of gastroenterology and hepatology as Clinical Trial, Journal Article, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15641209-2018-12-01-b9b14dc42eb4"]},{"id":"paragraph-1","text":"PubMed lists PMID 15641209 in Journal of gastroenterology and hepatology as Clinical Trial, Journal Article, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15641209-2018-12-01-b9b14dc42eb4"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-15641209-2018-12-01-b9b14dc42eb4"]}],"sources":[{"id":"pubmed-observation-pmid-15641209-2018-12-01-b9b14dc42eb4","name":"PubMed","sourceClass":"A","title":"Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment. · retained source version 1:2018-12-01:current:b9b14dc42eb441555b20b11c2ebce965e8fd6edfbf4488822c2604cb7313177b","url":"https://pubmed.ncbi.nlm.nih.gov/15641209/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"162b6303001fedbcb0a3759108aea0ebe68b7a67e0a0d386b2ff31cdd94e20fd","tierARecordSha256":"cdbaed88b75596739c63f86a0554c2960dca774cb9eaadecf16d7e01334ccba2"},"integrity":{"algorithm":"sha256","contentSha256":"e87b59cab7e7275a5fd01d1ba5d2450de0dc857e7b839afe941197272a044db5"}},"pubmed-pmid-16307501-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-16307501-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-16307501-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-16307501-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-16307501-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-16307501-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-16307501-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-03","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymalfasin for the treatment of chronic hepatitis C infection.","sourceIds":["pubmed-observation-pmid-16307501-2018-12-03-bccf74193a35"]},{"id":"summary","text":"PubMed lists PMID 16307501 in Expert review of anti-infective therapy as Journal Article, Review, with publication-date metadata of 2005-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-16307501-2018-12-03-bccf74193a35"]},{"id":"paragraph-1","text":"PubMed lists PMID 16307501 in Expert review of anti-infective therapy as Journal Article, Review, with publication-date metadata of 2005-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-16307501-2018-12-03-bccf74193a35"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-16307501-2018-12-03-bccf74193a35"]}],"sources":[{"id":"pubmed-observation-pmid-16307501-2018-12-03-bccf74193a35","name":"PubMed","sourceClass":"A","title":"Thymalfasin for the treatment of chronic hepatitis C infection. · retained source version 1:2018-12-03:current:bccf74193a359ee75f2303ec02088bdb9a97e40beee7000e5602752c5469333d","url":"https://pubmed.ncbi.nlm.nih.gov/16307501/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"174d6f849a3e4dbda6e7cdb77a474e1016ca6dc369ff6288bcfc0a561f11f5f1","tierARecordSha256":"e03696567e81b1286dda702ea6cad08681dedf10fbc859e3c863e5858803787d"},"integrity":{"algorithm":"sha256","contentSha256":"7775df9959c74352ec2d4611e824ba1a16fe247f2ef7220b94634b34425e1bcb"}},"pubmed-pmid-17600281-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-17600281-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-17600281-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-17600281-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-17600281-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-17600281-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-17600281-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymosin alpha 1 as an adjunct to influenza vaccination in the elderly: rationale and trial summaries.","sourceIds":["pubmed-observation-pmid-17600281-2018-12-01-16def7529435"]},{"id":"summary","text":"PubMed lists PMID 17600281 in Annals of the New York Academy of Sciences as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2007-06-28 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17600281-2018-12-01-16def7529435"]},{"id":"paragraph-1","text":"PubMed lists PMID 17600281 in Annals of the New York Academy of Sciences as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2007-06-28 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17600281-2018-12-01-16def7529435"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-17600281-2018-12-01-16def7529435"]}],"sources":[{"id":"pubmed-observation-pmid-17600281-2018-12-01-16def7529435","name":"PubMed","sourceClass":"A","title":"Thymosin alpha 1 as an adjunct to influenza vaccination in the elderly: rationale and trial summaries. · retained source version 1:2018-12-01:current:16def7529435b9d2cda3da4fbb0700aa0a3dbb6697980dad7ed5f785e58f1098","url":"https://pubmed.ncbi.nlm.nih.gov/17600281/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"10f7befcb86ac460918545df517e44ebd4e1cd10bdfcf3fe93e5efc97f286ce7","tierARecordSha256":"acbaa2d2b542031fbef2000ddbefbabcdfb7ff029b2a275c4c2fc96925a8882f"},"integrity":{"algorithm":"sha256","contentSha256":"b5d5cd81b0f5b29a343dca8ebf649d58c95ff02022028b31bbb03f9ec0c91afd"}},"pubmed-pmid-18410608-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-18410608-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-18410608-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-18410608-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-18410608-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-18410608-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-18410608-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.","sourceIds":["pubmed-observation-pmid-18410608-2018-12-01-e36da2b8e3fa"]},{"id":"summary","text":"PubMed lists PMID 18410608 in Journal of gastroenterology and hepatology as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-05 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18410608-2018-12-01-e36da2b8e3fa"]},{"id":"paragraph-1","text":"PubMed lists PMID 18410608 in Journal of gastroenterology and hepatology as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-05 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18410608-2018-12-01-e36da2b8e3fa"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-18410608-2018-12-01-e36da2b8e3fa"]}],"sources":[{"id":"pubmed-observation-pmid-18410608-2018-12-01-e36da2b8e3fa","name":"PubMed","sourceClass":"A","title":"Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study. · retained source version 1:2018-12-01:current:e36da2b8e3fa4c36ee6530e7f758f690da3ade5c4468c5d684653014d3d3101a","url":"https://pubmed.ncbi.nlm.nih.gov/18410608/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"272f1694ef10afc12db4d3c417d856c398e2ced5c330b879527cc5212c709be7","tierARecordSha256":"2836ea61bef879f922b540b59c84a6f23733d0508e3c512047d38a5b8358b39b"},"integrity":{"algorithm":"sha256","contentSha256":"fc4058edf5bc95b30e5c9e0cdc8e2a96c96b01703163c4afaeb507521dc616f9"}},"pubmed-pmid-19033321-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19033321-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-19033321-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19033321-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-19033321-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-19033321-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-19033321-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1.","sourceIds":["pubmed-observation-pmid-19033321-2018-12-01-dd9c0bfa8ed1"]},{"id":"summary","text":"PubMed lists PMID 19033321 in Journal of intensive care medicine as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2008-11-25 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19033321-2018-12-01-dd9c0bfa8ed1"]},{"id":"paragraph-1","text":"PubMed lists PMID 19033321 in Journal of intensive care medicine as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2008-11-25 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19033321-2018-12-01-dd9c0bfa8ed1"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19033321-2018-12-01-dd9c0bfa8ed1"]}],"sources":[{"id":"pubmed-observation-pmid-19033321-2018-12-01-dd9c0bfa8ed1","name":"PubMed","sourceClass":"A","title":"A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1. · retained source version 1:2018-12-01:current:dd9c0bfa8ed11d16fd5d8389973401c7bd2a046c069b364cf108d964bfbcabfb","url":"https://pubmed.ncbi.nlm.nih.gov/19033321/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"eb264fa83cab02b2c6505aae09f4b37d4b676b4359e1f9c346be875f48e08e32","tierARecordSha256":"efb5e32842532d511528293ad11811dbf754428854c3e3f3a30048b5e6f62b5a"},"integrity":{"algorithm":"sha256","contentSha256":"5a9d0b077b3d07d4d7ece6d7e9731713b934683ae37788eeedd05ee388655c96"}},"pubmed-pmid-19392576-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19392576-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-19392576-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19392576-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-19392576-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-19392576-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-19392576-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2022-03-16","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"From lab to bedside: emerging clinical applications of thymosin alpha 1.","sourceIds":["pubmed-observation-pmid-19392576-2022-03-16-bffda92a1abc"]},{"id":"summary","text":"PubMed lists PMID 19392576 in Expert opinion on biological therapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-05 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19392576-2022-03-16-bffda92a1abc"]},{"id":"paragraph-1","text":"PubMed lists PMID 19392576 in Expert opinion on biological therapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-05 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19392576-2022-03-16-bffda92a1abc"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19392576-2022-03-16-bffda92a1abc"]}],"sources":[{"id":"pubmed-observation-pmid-19392576-2022-03-16-bffda92a1abc","name":"PubMed","sourceClass":"A","title":"From lab to bedside: emerging clinical applications of thymosin alpha 1. · retained source version 1:2022-03-16:current:bffda92a1abc3f88971609b152f0abbfa89350ba8b2f3b400243793c62b19034","url":"https://pubmed.ncbi.nlm.nih.gov/19392576/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"67a3047587d5b8eead8bc1748ac6360f6bd3f8d77325fb4c29443d7b134db11b","tierARecordSha256":"1c4f040725ce0d8cbcf8f0f591e73033e5f52feb0820467bce2d677ba3c24caf"},"integrity":{"algorithm":"sha256","contentSha256":"1e2b2963e4a6dbbe18af6567b83a50d3cfb3251a9d8a35a5a9b6e32824e475ae"}},"pubmed-pmid-19467157-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19467157-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-19467157-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19467157-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-19467157-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-19467157-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-19467157-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2024-05-16","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis.","sourceIds":["pubmed-observation-pmid-19467157-2024-05-16-f0c75ce95f3d"]},{"id":"summary","text":"PubMed lists PMID 19467157 in Virology journal as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-05-25 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19467157-2024-05-16-f0c75ce95f3d"]},{"id":"paragraph-1","text":"PubMed lists PMID 19467157 in Virology journal as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-05-25 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19467157-2024-05-16-f0c75ce95f3d"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19467157-2024-05-16-f0c75ce95f3d"]}],"sources":[{"id":"pubmed-observation-pmid-19467157-2024-05-16-f0c75ce95f3d","name":"PubMed","sourceClass":"A","title":"Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis. · retained source version 1:2024-05-16:current:f0c75ce95f3d3026dfd1a0a546146741a992dfaf5d091833a011b7710e5046a8","url":"https://pubmed.ncbi.nlm.nih.gov/19467157/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"62eecdd586e55253cb83090ceb4cd9e4858c211dd699d46eb216e7b69192f83e","tierARecordSha256":"23185279a13df2ba44ad864091eb7278181ded558cc004cec8d29fef92cd791d"},"integrity":{"algorithm":"sha256","contentSha256":"29d72004eab4ecc560429f230ea308e72f5f1c2e9f229a645cc6e88f54703511"}},"pubmed-pmid-20194853-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-20194853-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-20194853-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-20194853-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20194853-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-20194853-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-20194853-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2025-04-28","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.","sourceIds":["pubmed-observation-pmid-20194853-2025-04-28-f8276733103c"]},{"id":"summary","text":"PubMed lists PMID 20194853 in Journal of clinical oncology : official journal of the American Society of Clinical Oncology as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2010-03-01 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20194853-2025-04-28-f8276733103c"]},{"id":"paragraph-1","text":"PubMed lists PMID 20194853 in Journal of clinical oncology : official journal of the American Society of Clinical Oncology as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2010-03-01 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20194853-2025-04-28-f8276733103c"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-20194853-2025-04-28-f8276733103c"]}],"sources":[{"id":"pubmed-observation-pmid-20194853-2025-04-28-f8276733103c","name":"PubMed","sourceClass":"A","title":"Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma. · retained source version 1:2025-04-28:current:f8276733103c11208a9ad634a14192fab92805dc2adca3d1f5de1b38fdd3171c","url":"https://pubmed.ncbi.nlm.nih.gov/20194853/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b0f38d6bb547e493e32c8d9786396330613280f827b205fcc55943771f767d8e","tierARecordSha256":"a5eaff7594e1180d35de866cde224347221ff2b7fde60ae66eda0d07c9179659"},"integrity":{"algorithm":"sha256","contentSha256":"ec89e4416ec91454ce54601445256701a3466612718326c2e2d8d91e9df9ceb7"}},"pubmed-pmid-20536445-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-20536445-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-20536445-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-20536445-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536445-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-20536445-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-20536445-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.","sourceIds":["pubmed-observation-pmid-20536445-2018-12-01-fcd077bef0ee"]},{"id":"summary","text":"PubMed lists PMID 20536445 in Annals of the New York Academy of Sciences as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20536445-2018-12-01-fcd077bef0ee"]},{"id":"paragraph-1","text":"PubMed lists PMID 20536445 in Annals of the New York Academy of Sciences as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20536445-2018-12-01-fcd077bef0ee"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-20536445-2018-12-01-fcd077bef0ee"]}],"sources":[{"id":"pubmed-observation-pmid-20536445-2018-12-01-fcd077bef0ee","name":"PubMed","sourceClass":"A","title":"Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1. · retained source version 1:2018-12-01:current:fcd077bef0ee56aa3ff03b18a914df8fbe1844505a44eb243c4bf706271734f2","url":"https://pubmed.ncbi.nlm.nih.gov/20536445/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7da4b02e4f0a4586e8be7f2664e353eb881c6c55fe417d9fb548433eb2c9af53","tierARecordSha256":"00ee70383a8230afb857135f8c1906e14a6b112d10e9225f5238881bfbaafeb4"},"integrity":{"algorithm":"sha256","contentSha256":"ce4457f3f4766fd1c9e7833f7ca560d1bff67118def1f797b667ec98d001a7b9"}},"pubmed-pmid-20536460-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-20536460-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-20536460-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-20536460-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536460-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-20536460-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-20536460-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2026-01-28","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymosin alpha 1: past clinical experience and future promise.","sourceIds":["pubmed-observation-pmid-20536460-2026-01-28-219ebe73a316"]},{"id":"summary","text":"PubMed lists PMID 20536460 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20536460-2026-01-28-219ebe73a316"]},{"id":"paragraph-1","text":"PubMed lists PMID 20536460 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20536460-2026-01-28-219ebe73a316"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-20536460-2026-01-28-219ebe73a316"]}],"sources":[{"id":"pubmed-observation-pmid-20536460-2026-01-28-219ebe73a316","name":"PubMed","sourceClass":"A","title":"Thymosin alpha 1: past clinical experience and future promise. · retained source version 1:2026-01-28:current:219ebe73a316eb4e41acbca4fc5a64cb4133a5cc476ee2644fcab8664a089348","url":"https://pubmed.ncbi.nlm.nih.gov/20536460/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ac50f64c0fd04edb4b08c1f240d162a7eb7835cb836cfafe6f964e001f0a23e9","tierARecordSha256":"8e71904a712dd8a95866b9d05a20eaad5e1d660678838beec846181a7490e5c6"},"integrity":{"algorithm":"sha256","contentSha256":"23a90c8381d64aa595449f48de5eca423f7fe6b2a6a1eebfbc6746b916d092f7"}},"pubmed-pmid-20536461-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-20536461-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-20536461-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-20536461-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536461-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-20536461-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-20536461-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof.","sourceIds":["pubmed-observation-pmid-20536461-2018-12-01-ef2debece004"]},{"id":"summary","text":"PubMed lists PMID 20536461 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20536461-2018-12-01-ef2debece004"]},{"id":"paragraph-1","text":"PubMed lists PMID 20536461 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20536461-2018-12-01-ef2debece004"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-20536461-2018-12-01-ef2debece004"]}],"sources":[{"id":"pubmed-observation-pmid-20536461-2018-12-01-ef2debece004","name":"PubMed","sourceClass":"A","title":"Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof. · retained source version 1:2018-12-01:current:ef2debece00452abe1176a215d8bac0538153ba20e43ed14123b15de6ad1ddab","url":"https://pubmed.ncbi.nlm.nih.gov/20536461/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b81d40b04f0b210a120827273ed7fcb57a5a2c66276be7d82dbaa604e0c42d81","tierARecordSha256":"03fcf2ab3108d4f2b2df12d8c3c5d6792a9f4c2b2b37533a5858e212fd5df867"},"integrity":{"algorithm":"sha256","contentSha256":"ff58de5c6366a76173e3c0ea03d2b0187cfc7c14ee6b64aa98bfb09a5d252cc7"}},"pubmed-pmid-20536462-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-20536462-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-20536462-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-20536462-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-20536462-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-20536462-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-20536462-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2026-01-28","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymalfasin in the treatment of hepatitis B and C.","sourceIds":["pubmed-observation-pmid-20536462-2026-01-28-9c7e9805ba60"]},{"id":"summary","text":"PubMed lists PMID 20536462 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20536462-2026-01-28-9c7e9805ba60"]},{"id":"paragraph-1","text":"PubMed lists PMID 20536462 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20536462-2026-01-28-9c7e9805ba60"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-20536462-2026-01-28-9c7e9805ba60"]}],"sources":[{"id":"pubmed-observation-pmid-20536462-2026-01-28-9c7e9805ba60","name":"PubMed","sourceClass":"A","title":"Thymalfasin in the treatment of hepatitis B and C. · retained source version 1:2026-01-28:current:9c7e9805ba601906e0e796df14675ba76015a25b36580c30c2847d6f1085ca52","url":"https://pubmed.ncbi.nlm.nih.gov/20536462/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"259c9371326c0adafc803de3470303c0caa295058d45a5b66d7fd0d7b32532f1","tierARecordSha256":"edce33b77aabd08511bd90ff9ad9b48b43a795b99b3e49e98b80ac017aff2cea"},"integrity":{"algorithm":"sha256","contentSha256":"8b9a3e05e272caf7cbf2938a320a043bbb3d13cc1c62c2f5ba389ef20854d900"}},"pubmed-pmid-21272455-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-21272455-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-21272455-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-21272455-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-21272455-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-21272455-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-21272455-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"[Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis].","sourceIds":["pubmed-observation-pmid-21272455-2018-12-01-830b7ea73488"]},{"id":"summary","text":"PubMed lists PMID 21272455 in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology as Journal Article, Meta-Analysis, with publication-date metadata of 2011-01 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21272455-2018-12-01-830b7ea73488"]},{"id":"paragraph-1","text":"PubMed lists PMID 21272455 in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology as Journal Article, Meta-Analysis, with publication-date metadata of 2011-01 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21272455-2018-12-01-830b7ea73488"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-21272455-2018-12-01-830b7ea73488"]}],"sources":[{"id":"pubmed-observation-pmid-21272455-2018-12-01-830b7ea73488","name":"PubMed","sourceClass":"A","title":"[Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis]. · retained source version 1:2018-12-01:current:830b7ea73488759109790a60027858a4f967e371ebb365ee07b071325b4bf919","url":"https://pubmed.ncbi.nlm.nih.gov/21272455/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"54dcd0c8d7a0f410ca4ebf1925ede90c23afd10ab19df03595723f749ad7aa84","tierARecordSha256":"7ddfef9151eaaa5ac4ed9992ad707a78d39a395c09bf476474c74951f65a7bda"},"integrity":{"algorithm":"sha256","contentSha256":"32d41965cf74a4431aac9df53c06f67d59887e52663ae744ba2b63aefdf16c2c"}},"pubmed-pmid-22010537-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-22010537-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-22010537-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-22010537-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-22010537-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-22010537-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-22010537-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review.","sourceIds":["pubmed-observation-pmid-22010537-2018-12-01-b34bb820cf24"]},{"id":"summary","text":"PubMed lists PMID 22010537 in Journal of preventive medicine and hygiene as Journal Article, Review, with publication-date metadata of 2011-09 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22010537-2018-12-01-b34bb820cf24"]},{"id":"paragraph-1","text":"PubMed lists PMID 22010537 in Journal of preventive medicine and hygiene as Journal Article, Review, with publication-date metadata of 2011-09 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22010537-2018-12-01-b34bb820cf24"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-22010537-2018-12-01-b34bb820cf24"]}],"sources":[{"id":"pubmed-observation-pmid-22010537-2018-12-01-b34bb820cf24","name":"PubMed","sourceClass":"A","title":"Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review. · retained source version 1:2018-12-01:current:b34bb820cf24599181ea17e2eed3e60171e2afc0e9975bb6999f46239441a773","url":"https://pubmed.ncbi.nlm.nih.gov/22010537/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"624d50ba9d6c866ca970da7e894f95fd2d6079bdc5cfa8094b0bc3048f1302e8","tierARecordSha256":"2a6f59d7810a9d4f577cb44cc1f58b53d81c19e41a604ab37dbb9fa630191552"},"integrity":{"algorithm":"sha256","contentSha256":"f86dd190e2b26b04136b2872b612603401cdd7be771d6d46612bcf9283f4d9a1"}},"pubmed-pmid-22233415-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-22233415-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-22233415-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-22233415-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-22233415-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-22233415-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-22233415-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?","sourceIds":["pubmed-observation-pmid-22233415-2018-12-01-b8e16df877b2"]},{"id":"summary","text":"PubMed lists PMID 22233415 in Journal of viral hepatitis as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2012-01 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22233415-2018-12-01-b8e16df877b2"]},{"id":"paragraph-1","text":"PubMed lists PMID 22233415 in Journal of viral hepatitis as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2012-01 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22233415-2018-12-01-b8e16df877b2"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-22233415-2018-12-01-b8e16df877b2"]}],"sources":[{"id":"pubmed-observation-pmid-22233415-2018-12-01-b8e16df877b2","name":"PubMed","sourceClass":"A","title":"Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role? · retained source version 1:2018-12-01:current:b8e16df877b207e58840cfc81cb893820fe12e45e32226958cf53a1ac854ec6a","url":"https://pubmed.ncbi.nlm.nih.gov/22233415/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ce47ceacac3ac4d521f44bbc2548c224f8eb42a7f353abf0e402a3d1dd537337","tierARecordSha256":"b7766c89eac65ad39c35de5bd378b944c643f53240f5e9c267be6e759801a546"},"integrity":{"algorithm":"sha256","contentSha256":"2effd1b924983893d749e72a2a91834316560856c4d69ab3765ba09853369caf"}},"pubmed-pmid-28106477-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-28106477-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-28106477-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-28106477-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-28106477-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-28106477-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-28106477-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2018-12-02","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymosin alpha 1 and HIV-1: recent advances and future perspectives.","sourceIds":["pubmed-observation-pmid-28106477-2018-12-02-3fa552d98ba7"]},{"id":"summary","text":"PubMed lists PMID 28106477 in Future microbiology as Journal Article, Review, with publication-date metadata of 2017-01-20 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28106477-2018-12-02-3fa552d98ba7"]},{"id":"paragraph-1","text":"PubMed lists PMID 28106477 in Future microbiology as Journal Article, Review, with publication-date metadata of 2017-01-20 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28106477-2018-12-02-3fa552d98ba7"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-28106477-2018-12-02-3fa552d98ba7"]}],"sources":[{"id":"pubmed-observation-pmid-28106477-2018-12-02-3fa552d98ba7","name":"PubMed","sourceClass":"A","title":"Thymosin alpha 1 and HIV-1: recent advances and future perspectives. · retained source version 1:2018-12-02:current:3fa552d98ba79ef3a09936d5d3224b42e29c37ef513b8496b672c71219036e96","url":"https://pubmed.ncbi.nlm.nih.gov/28106477/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c2a6daff8d19705be7bfb5aef252e7c2b457d70373e6d2a19a657d9ea92c3583","tierARecordSha256":"988e81db411e5f8325a1e9459b961c39cc00739c702ca48dc8bf48e61841a372"},"integrity":{"algorithm":"sha256","contentSha256":"a50875b8b3545e740d78bf71dec64a605f825de292592c2ae73f5ae207f61587"}},"pubmed-pmid-30063860-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-30063860-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-30063860-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-30063860-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-30063860-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-30063860-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-30063860-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2019-01-11","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study.","sourceIds":["pubmed-observation-pmid-30063860-2019-01-11-f8dc3b0f5347"]},{"id":"summary","text":"PubMed lists PMID 30063860 in Expert opinion on biological therapy as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30063860-2019-01-11-f8dc3b0f5347"]},{"id":"paragraph-1","text":"PubMed lists PMID 30063860 in Expert opinion on biological therapy as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30063860-2019-01-11-f8dc3b0f5347"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-30063860-2019-01-11-f8dc3b0f5347"]}],"sources":[{"id":"pubmed-observation-pmid-30063860-2019-01-11-f8dc3b0f5347","name":"PubMed","sourceClass":"A","title":"Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study. · retained source version 1:2019-01-11:current:f8dc3b0f53473654ac4b4e0f3400f5017a81f345a42a720d5f5bb91e71a9847e","url":"https://pubmed.ncbi.nlm.nih.gov/30063860/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"34fbfb6556cc3f5acfb66a3ea5967d617652a0c704dbdbcaee035d7a5f2eba9a","tierARecordSha256":"933723cd6691491d89fe47f56885e5e7d7fd17cbde81891bbb050c2de09d6cdb"},"integrity":{"algorithm":"sha256","contentSha256":"5181762db5f38490b95fb022f7bb499754050174370b1c086990f1a5a8ac9bb5"}},"pubmed-pmid-30063864-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-30063864-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-30063864-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-30063864-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-30063864-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-30063864-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-30063864-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2019-06-25","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Serum thymosin alpha 1 levels in normal and pathological conditions.","sourceIds":["pubmed-observation-pmid-30063864-2019-06-25-e86d24d6c706"]},{"id":"summary","text":"PubMed lists PMID 30063864 in Expert opinion on biological therapy as Journal Article, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30063864-2019-06-25-e86d24d6c706"]},{"id":"paragraph-1","text":"PubMed lists PMID 30063864 in Expert opinion on biological therapy as Journal Article, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30063864-2019-06-25-e86d24d6c706"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-30063864-2019-06-25-e86d24d6c706"]}],"sources":[{"id":"pubmed-observation-pmid-30063864-2019-06-25-e86d24d6c706","name":"PubMed","sourceClass":"A","title":"Serum thymosin alpha 1 levels in normal and pathological conditions. · retained source version 1:2019-06-25:current:e86d24d6c7066692e2de233a75fb5d7d2b8b311724592a2a154a889f0dffbd00","url":"https://pubmed.ncbi.nlm.nih.gov/30063864/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fcbdc767f53355fea6542ab46c865132820cc00917a6b39aa949da836f3b5c2a","tierARecordSha256":"a558e2ce6d154938dbf6ba04716f26cdef11e2f9916c028a5968f27d79bd9919"},"integrity":{"algorithm":"sha256","contentSha256":"ba48fd951ea1e7fc1e6a169615fe5fcdfb089908bb89a8d97fbadd091197a24c"}},"pubmed-pmid-30063866-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-30063866-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-30063866-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-30063866-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-30063866-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-30063866-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-30063866-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2019-06-25","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymosin alpha 1 treatment for patients with sepsis.","sourceIds":["pubmed-observation-pmid-30063866-2019-06-25-4a89748ecabb"]},{"id":"summary","text":"PubMed lists PMID 30063866 in Expert opinion on biological therapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30063866-2019-06-25-4a89748ecabb"]},{"id":"paragraph-1","text":"PubMed lists PMID 30063866 in Expert opinion on biological therapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30063866-2019-06-25-4a89748ecabb"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-30063866-2019-06-25-4a89748ecabb"]}],"sources":[{"id":"pubmed-observation-pmid-30063866-2019-06-25-4a89748ecabb","name":"PubMed","sourceClass":"A","title":"Thymosin alpha 1 treatment for patients with sepsis. · retained source version 1:2019-06-25:current:4a89748ecabb725ac303127ec4e8099ef7ec603f248f09a7158c7de5af54a272","url":"https://pubmed.ncbi.nlm.nih.gov/30063866/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"365a3b6618e0a7ea266c99ad9469c4f02b706f996bed5ab1c186133e204ce49d","tierARecordSha256":"0fdf3c70c56c8f60b57de2f686728926617220ea7a90060f16794e5a11a0ee79"},"integrity":{"algorithm":"sha256","contentSha256":"512abd2779360063a3f0a74a9b81ad51064266a37e6fc7ceb9de3a4a6fb00391"}},"pubmed-pmid-33362999-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-33362999-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-33362999-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-33362999-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-33362999-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-33362999-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-33362999-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2020-12-29","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymosin alpha 1: A comprehensive review of the literature.","sourceIds":["pubmed-observation-pmid-33362999-2020-12-29-96f371610863"]},{"id":"summary","text":"PubMed lists PMID 33362999 in World journal of virology as Journal Article, Review, with publication-date metadata of 2020-12-15 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-33362999-2020-12-29-96f371610863"]},{"id":"paragraph-1","text":"PubMed lists PMID 33362999 in World journal of virology as Journal Article, Review, with publication-date metadata of 2020-12-15 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-33362999-2020-12-29-96f371610863"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-33362999-2020-12-29-96f371610863"]}],"sources":[{"id":"pubmed-observation-pmid-33362999-2020-12-29-96f371610863","name":"PubMed","sourceClass":"A","title":"Thymosin alpha 1: A comprehensive review of the literature. · retained source version 1:2020-12-29:current:96f371610863b6832c5115cbae5800623e3cf9342dceaaf04af184bc9285d9ef","url":"https://pubmed.ncbi.nlm.nih.gov/33362999/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4e98b2366c6a889cb03ee7f1e697b0d6aa7a0a8b8ece1a0e47fd5c8b3ad93ce6","tierARecordSha256":"1a6cd73b4ae8ee1bc7bd7b87265f7cfa9435eba2665e5fcb14b0a7b4ea6ace7a"},"integrity":{"algorithm":"sha256","contentSha256":"c69d50c8110ecd9822c06a0e4ebbdd082ed5d2af2a17eaa8ad9c4080736d3bda"}},"pubmed-pmid-38903817-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38903817-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-38903817-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38903817-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-38903817-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-38903817-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-38903817-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2024-06-22","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Phenotypic drug discovery: a case for thymosin alpha-1.","sourceIds":["pubmed-observation-pmid-38903817-2024-06-22-1868701eb2fd"]},{"id":"summary","text":"PubMed lists PMID 38903817 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2024-06-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38903817-2024-06-22-1868701eb2fd"]},{"id":"paragraph-1","text":"PubMed lists PMID 38903817 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2024-06-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38903817-2024-06-22-1868701eb2fd"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38903817-2024-06-22-1868701eb2fd"]}],"sources":[{"id":"pubmed-observation-pmid-38903817-2024-06-22-1868701eb2fd","name":"PubMed","sourceClass":"A","title":"Phenotypic drug discovery: a case for thymosin alpha-1. · retained source version 1:2024-06-22:current:1868701eb2fd1a0c736c5b24e4c20c1b9a6929abbba785eb518a23d7ef017fb7","url":"https://pubmed.ncbi.nlm.nih.gov/38903817/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1bb8dffe2a02d54726e7241c355b0530a3f38981fa9dbd8cb90a820e457c250a","tierARecordSha256":"6d65ca5dca32aab19e8d4b925f5397e320d44d89203c67c1db7f4beb0c0b3f9a"},"integrity":{"algorithm":"sha256","contentSha256":"971cf04737d068ad6ff282284bc31fba4532dad0a6b30556ef7ac1a9bd40b223"}},"pubmed-pmid-39648386-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-39648386-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-39648386-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-39648386-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-39648386-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-39648386-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-39648386-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2024-12-16","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.","sourceIds":["pubmed-observation-pmid-39648386-2024-12-16-7ec48cc3db08"]},{"id":"summary","text":"PubMed lists PMID 39648386 in Journal of the College of Physicians and Surgeons--Pakistan : JCPSP as Systematic Review, Journal Article, Meta-Analysis, with publication-date metadata of 2024-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-39648386-2024-12-16-7ec48cc3db08"]},{"id":"paragraph-1","text":"PubMed lists PMID 39648386 in Journal of the College of Physicians and Surgeons--Pakistan : JCPSP as Systematic Review, Journal Article, Meta-Analysis, with publication-date metadata of 2024-12 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-39648386-2024-12-16-7ec48cc3db08"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-39648386-2024-12-16-7ec48cc3db08"]}],"sources":[{"id":"pubmed-observation-pmid-39648386-2024-12-16-7ec48cc3db08","name":"PubMed","sourceClass":"A","title":"Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. · retained source version 1:2024-12-16:current:7ec48cc3db08aab3eb72022a99167f50301ea021259fe1ef0d1c93a6dc778825","url":"https://pubmed.ncbi.nlm.nih.gov/39648386/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"36c7754b6ea716ad7b512b0daa8414bd48db11ff116da168f0d80124eed662eb","tierARecordSha256":"b11bacb84214c1f6147ae7e4ab32b409bdaf0ba648498dbb9b44ff4ca04c985d"},"integrity":{"algorithm":"sha256","contentSha256":"bcba6c5a557bb416f1cdfcda869de6ae8ec3780a9af0d1ebaac8929a54efe99b"}},"pubmed-pmid-41373628-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41373628-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-41373628-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41373628-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-41373628-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-41373628-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-41373628-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2025-12-14","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Aging and Thymosin Alpha-1.","sourceIds":["pubmed-observation-pmid-41373628-2025-12-14-4306cfc99eb5"]},{"id":"summary","text":"PubMed lists PMID 41373628 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2025-11-27 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41373628-2025-12-14-4306cfc99eb5"]},{"id":"paragraph-1","text":"PubMed lists PMID 41373628 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2025-11-27 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41373628-2025-12-14-4306cfc99eb5"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41373628-2025-12-14-4306cfc99eb5"]}],"sources":[{"id":"pubmed-observation-pmid-41373628-2025-12-14-4306cfc99eb5","name":"PubMed","sourceClass":"A","title":"Aging and Thymosin Alpha-1. · retained source version 1:2025-12-14:current:4306cfc99eb51a5989e82d127a8ba6a3047b5c75426373f7713a1c47411a6cac","url":"https://pubmed.ncbi.nlm.nih.gov/41373628/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"298b6a08be09827987ec429f6e7955aef00df2c5272058d4b909c54f987ac37f","tierARecordSha256":"546d5913a141fb8dfb010ae402fc37fc81a442a265732f2d816802f8a9affd21"},"integrity":{"algorithm":"sha256","contentSha256":"6517c4d45db77169760b526ae693f5950d368c2777d8fa8168dcf390a6dfa836"}},"pubmed-pmid-41749205-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41749205-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-41749205-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41749205-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-41749205-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-41749205-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-41749205-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2026-09-14","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Neoadjuvant immunochemotherapy plus thymalfasin in locally advanced gastric cancer: a prospective clinical trial.","sourceIds":["pubmed-observation-pmid-41749205-2026-09-14-69d068216aa5"]},{"id":"summary","text":"PubMed lists PMID 41749205 in BMC medicine as Journal Article, Clinical Trial, Phase II, with publication-date metadata of 2026-02-26 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41749205-2026-09-14-69d068216aa5"]},{"id":"paragraph-1","text":"PubMed lists PMID 41749205 in BMC medicine as Journal Article, Clinical Trial, Phase II, with publication-date metadata of 2026-02-26 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41749205-2026-09-14-69d068216aa5"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41749205-2026-09-14-69d068216aa5"]}],"sources":[{"id":"pubmed-observation-pmid-41749205-2026-09-14-69d068216aa5","name":"PubMed","sourceClass":"A","title":"Neoadjuvant immunochemotherapy plus thymalfasin in locally advanced gastric cancer: a prospective clinical trial. · retained source version 1:2026-09-14:current:69d068216aa50f316e5953d91bcee4c29ce394f8061dde437de0357d548d4d3e","url":"https://pubmed.ncbi.nlm.nih.gov/41749205/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"62ee8d222519a7dba21e3c15c2d4faa2cf3c4ac514b6bd760d9855eb3ad64c81","tierARecordSha256":"4b7e4c04f1389781fe7f15da4ae76a180ef2a396c13534ffcceb39dbd0468b8d"},"integrity":{"algorithm":"sha256","contentSha256":"ffae1b2e185e36a365192045015afa0eb45a6d294f7eb267ed92cf7fa0a1c857"}},"pubmed-pmid-42797537-thymosin-alpha-1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42797537-thymosin-alpha-1:v1","objectPathId":"pubmed-pmid-42797537-thymosin-alpha-1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42797537-thymosin-alpha-1/","json":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.json#pubmed-pmid-42797537-thymosin-alpha-1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/thymosin-alpha-1.md#pubmed-pmid-42797537-thymosin-alpha-1-v1"},"story":{"slug":"pubmed-pmid-42797537-thymosin-alpha-1","version":1,"domain":"Literature metadata","dateInSource":"2026-09-29","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["thymosin-alpha-1"],"peptides":[{"slug":"thymosin-alpha-1","url":"https://peptidescanner.com/peptides/thymosin-alpha-1/"}]},"claims":[{"id":"headline","text":"Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.","sourceIds":["pubmed-observation-pmid-42797537-2026-09-29-f5d603c32e01"]},{"id":"summary","text":"PubMed lists PMID 42797537 in Pharmaceuticals (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2026-09-19 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42797537-2026-09-29-f5d603c32e01"]},{"id":"paragraph-1","text":"PubMed lists PMID 42797537 in Pharmaceuticals (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2026-09-19 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42797537-2026-09-29-f5d603c32e01"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42797537-2026-09-29-f5d603c32e01"]}],"sources":[{"id":"pubmed-observation-pmid-42797537-2026-09-29-f5d603c32e01","name":"PubMed","sourceClass":"A","title":"Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review. · retained source version 1:2026-09-29:current:f5d603c32e01271e609945a4d8e4cd8b3521239cb60764f0fb7e0ce900183af5","url":"https://pubmed.ncbi.nlm.nih.gov/42797537/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"295546dd1337d58d274bb239c26f80a31b2a86d1edcf2d33cff034135432b3c2","tierARecordSha256":"97a04fb7a6f1b1d9b29ab6d0df63ece28398c458719b139e590d97559fdcb5af"},"integrity":{"algorithm":"sha256","contentSha256":"dd9ff7f53f8b5ca2b57684275d4d79980ba8935dd5ad9e664cae16dbc1d25d01"}}}}
